vs
Side-by-side financial comparison of Danaher Corporation (DHR) and Estée Lauder Companies (The) (EL). Click either name above to swap in a different company.
Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $4.2B, roughly 1.4× Estée Lauder Companies (The)). Danaher Corporation runs the higher net margin — 17.3% vs 3.8%, a 13.5% gap on every dollar of revenue. On growth, Estée Lauder Companies (The) posted the faster year-over-year revenue change (5.6% vs 3.7%). Over the past eight quarters, Estée Lauder Companies (The)'s revenue compounded faster (3.6% CAGR vs 1.8%).
Danaher CorporationDHREarnings & Financial Report
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...
Estée Lauder was an American businesswoman. She co-founded her eponymous cosmetics company with her husband, Joseph Lauter. Lauder was the only woman on Time magazine's 1998 list of the 20 most influential business geniuses of the 20th century.
DHR vs EL — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.0B | $4.2B |
| Net Profit | $1.0B | $162.0M |
| Gross Margin | 60.3% | 76.5% |
| Operating Margin | 22.6% | 9.5% |
| Net Margin | 17.3% | 3.8% |
| Revenue YoY | 3.7% | 5.6% |
| Net Profit YoY | 7.9% | 127.5% |
| EPS (diluted) | $1.45 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $4.2B | ||
| Q3 25 | $6.1B | $3.5B | ||
| Q2 25 | $5.9B | $3.4B | ||
| Q1 25 | $5.7B | $3.5B | ||
| Q4 24 | $6.5B | $4.0B | ||
| Q3 24 | $5.8B | $3.4B | ||
| Q2 24 | $5.7B | $3.9B |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $162.0M | ||
| Q3 25 | $908.0M | $47.0M | ||
| Q2 25 | $555.0M | $-546.0M | ||
| Q1 25 | $954.0M | $159.0M | ||
| Q4 24 | $1.1B | $-590.0M | ||
| Q3 24 | $818.0M | $-156.0M | ||
| Q2 24 | $907.0M | $-286.0M |
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | 76.5% | ||
| Q3 25 | 58.2% | 73.4% | ||
| Q2 25 | 59.3% | 72.0% | ||
| Q1 25 | 61.2% | 75.0% | ||
| Q4 24 | 59.5% | 76.1% | ||
| Q3 24 | 58.7% | 72.4% | ||
| Q2 24 | 59.7% | 71.8% |
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 9.5% | ||
| Q3 25 | 19.1% | 4.9% | ||
| Q2 25 | 12.8% | -11.4% | ||
| Q1 25 | 22.2% | 8.6% | ||
| Q4 24 | 21.8% | -14.5% | ||
| Q3 24 | 16.5% | -3.6% | ||
| Q2 24 | 20.3% | -6.0% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 3.8% | ||
| Q3 25 | 15.0% | 1.4% | ||
| Q2 25 | 9.3% | -16.0% | ||
| Q1 25 | 16.6% | 4.5% | ||
| Q4 24 | 16.6% | -14.7% | ||
| Q3 24 | 14.1% | -4.6% | ||
| Q2 24 | 15.8% | -7.4% |
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $0.44 | ||
| Q3 25 | $1.27 | $0.13 | ||
| Q2 25 | $0.77 | $-1.52 | ||
| Q1 25 | $1.32 | $0.44 | ||
| Q4 24 | $1.50 | $-1.64 | ||
| Q3 24 | $1.12 | $-0.43 | ||
| Q2 24 | $1.22 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $7.3B |
| Stockholders' EquityBook value | — | $4.0B |
| Total Assets | — | $19.6B |
| Debt / EquityLower = less leverage | — | 1.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $7.3B | ||
| Q3 25 | $16.9B | $7.3B | ||
| Q2 25 | $17.4B | $7.3B | ||
| Q1 25 | $16.5B | $7.3B | ||
| Q4 24 | $16.0B | $7.3B | ||
| Q3 24 | $17.5B | $7.3B | ||
| Q2 24 | $17.0B | $7.3B |
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $4.0B | ||
| Q3 25 | $51.1B | $3.9B | ||
| Q2 25 | $52.3B | $3.9B | ||
| Q1 25 | $50.8B | $4.3B | ||
| Q4 24 | $49.5B | $4.2B | ||
| Q3 24 | $51.3B | $5.1B | ||
| Q2 24 | $49.9B | $5.3B |
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $19.6B | ||
| Q3 25 | $79.9B | $19.3B | ||
| Q2 25 | $81.6B | $19.9B | ||
| Q1 25 | $79.1B | $19.9B | ||
| Q4 24 | $77.5B | $19.8B | ||
| Q3 24 | $80.6B | $21.3B | ||
| Q2 24 | $78.6B | $21.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 1.82× | ||
| Q3 25 | 0.33× | 1.88× | ||
| Q2 25 | 0.33× | 1.89× | ||
| Q1 25 | 0.32× | 1.68× | ||
| Q4 24 | 0.32× | 1.75× | ||
| Q3 24 | 0.34× | 1.44× | ||
| Q2 24 | 0.34× | 1.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | $1.1B |
| Free Cash FlowOCF − Capex | — | $1.0B |
| FCF MarginFCF / Revenue | — | 24.0% |
| Capex IntensityCapex / Revenue | 4.0% | 2.6% |
| Cash ConversionOCF / Net Profit | 1.28× | 6.94× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $1.1B | ||
| Q3 25 | $1.7B | $-340.0M | ||
| Q2 25 | $1.3B | $601.0M | ||
| Q1 25 | $1.3B | $284.0M | ||
| Q4 24 | $2.0B | $1.1B | ||
| Q3 24 | $1.5B | $-670.0M | ||
| Q2 24 | $1.4B | $889.0M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $1.0B | ||
| Q3 25 | $1.4B | $-436.0M | ||
| Q2 25 | $1.1B | $394.0M | ||
| Q1 25 | $1.1B | $162.0M | ||
| Q4 24 | $1.5B | $925.0M | ||
| Q3 24 | $1.2B | $-811.0M | ||
| Q2 24 | $1.1B | $672.0M |
| Q1 26 | — | — | ||
| Q4 25 | 25.5% | 24.0% | ||
| Q3 25 | 22.6% | -12.5% | ||
| Q2 25 | 18.4% | 11.6% | ||
| Q1 25 | 18.4% | 4.6% | ||
| Q4 24 | 23.0% | 23.1% | ||
| Q3 24 | 21.0% | -24.1% | ||
| Q2 24 | 19.7% | 17.4% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 2.6% | ||
| Q3 25 | 4.8% | 2.8% | ||
| Q2 25 | 4.2% | 6.1% | ||
| Q1 25 | 4.3% | 3.4% | ||
| Q4 24 | 7.9% | 3.3% | ||
| Q3 24 | 5.1% | 4.2% | ||
| Q2 24 | 5.0% | 5.6% |
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 6.94× | ||
| Q3 25 | 1.83× | -7.23× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.36× | 1.79× | ||
| Q4 24 | 1.86× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHR
Segment breakdown not available.
EL
| Skin Care | $2.1B | 49% |
| Makeup | $1.2B | 28% |
| Fragrance | $812.0M | 19% |
| Hair Care | $168.0M | 4% |
| Other | $31.0M | 1% |
